Terms: = Lung cancer AND EP300, ENSG00000100393, 2033, RP1-85F18_1, p300
209 results:
1. IL-17 induces NSCLC cell migration and invasion by elevating MMP19 gene transcription and expression through the interaction of p300-dependent STAT3-K631 acetylation and its Y705-phosphorylation.
Ge W; Li YA; Ruan Y; Wu N; Ma P; Xu T; Shu Y; Wang Y; Qiu W; Zhao C
Oncol Res; 2024; 32(4):625-641. PubMed ID: 38560562
[TBL] [Abstract] [Full Text] [Related]
2. Evolutionary trajectories of small cell lung cancer under therapy.
George J; Maas L; Abedpour N; Cartolano M; Kaiser L; Fischer RN; Scheel AH; Weber JP; Hellmich M; Bosco G; Volz C; Mueller C; Dahmen I; John F; Alves CP; Werr L; Panse JP; Kirschner M; Engel-Riedel W; Jürgens J; Stoelben E; Brockmann M; Grau S; Sebastian M; Stratmann JA; Kern J; Hummel HD; Hegedüs B; Schuler M; Plönes T; Aigner C; Elter T; Toepelt K; Ko YD; Kurz S; Grohé C; Serke M; Höpker K; Hagmeyer L; Doerr F; Hekmath K; Strapatsas J; Kambartel KO; Chakupurakal G; Busch A; Bauernfeind FG; Griesinger F; Luers A; Dirks W; Wiewrodt R; Luecke A; Rodermann E; Diel A; Hagen V; Severin K; Ullrich RT; Reinhardt HC; Quaas A; Bogus M; Courts C; Nürnberg P; Becker K; Achter V; Büttner R; Wolf J; Peifer M; Thomas RK
Nature; 2024 Mar; 627(8005):880-889. PubMed ID: 38480884
[TBL] [Abstract] [Full Text] [Related]
3. Acetyltransferase p300 Regulates Glucose Metabolic Reprogramming through Catalyzing Succinylation in lung cancer.
Ma Q; Zeng Q; Wang K; Qian M; Li J; Wang H; Zhang H; Jiang J; Chen Z; Huang W
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38256128
[TBL] [Abstract] [Full Text] [Related]
4. ep300 promotes lung cancer cell proliferation by regulating the oncogenic transcription of Hippo-YAP signaling pathway.
Li S; Shi J; Wang L; Zhang D; Zhang H
Biochem Biophys Res Commun; 2024 Jan; 692():149330. PubMed ID: 38048728
[TBL] [Abstract] [Full Text] [Related]
5. LINC00921 reduces lung cancer radiosensitivity by destabilizing NUDT21 and driving aberrant MED23 alternative polyadenylation.
Zhang N; Liu X; Huang L; Zeng J; Ma C; Han L; Li W; Yu J; Yang M
Cell Rep; 2023 Dec; 42(12):113479. PubMed ID: 37999979
[TBL] [Abstract] [Full Text] [Related]
6. LncRNA MIR31HG fosters stemness malignant features of non-small cell lung cancer via H3K4me1- and H3K27Ace-mediated GLI2 expression.
Chen W; Wang F; Yu X; Qi J; Dong H; Cui B; Zhang Q; Wu Y; An J; Ni N; Liu C; Han Y; Zhang S; Schmitt CA; Deng J; Yu Y; Du J
Oncogene; 2024 May; 43(18):1328-1340. PubMed ID: 37950038
[TBL] [Abstract] [Full Text] [Related]
7. Pembrolizumab plus chemotherapy versus chemotherapy in untreated advanced pleural mesothelioma in Canada, Italy, and France: a phase 3, open-label, randomised controlled trial.
Chu Q; Perrone F; Greillier L; Tu W; Piccirillo MC; Grosso F; Lo Russo G; Florescu M; Mencoboni M; Morabito A; Cecere FL; Ceresoli GL; Dawe DE; Zucali PA; Pagano M; Goffin JR; Sanchez ML; Gridelli C; Zalcman G; Quantin X; Westeel V; Gargiulo P; Delfanti S; Tu D; Lee CW; Leighl N; Sederias J; Brown-Walker P; Luo Y; Lantuejoul S; Tsao MS; Scherpereel A; Bradbury P; Laurie SA; Seymour L
Lancet; 2023 Dec; 402(10419):2295-2306. PubMed ID: 37931632
[TBL] [Abstract] [Full Text] [Related]
8. I-CBP112 declines overexpression of ATP-binding cassette transporters and sensitized drug-resistant MDA-MB-231 and A549 cell lines to chemotherapy drugs.
Strachowska M; Gronkowska K; Sobczak M; Grodzicka M; Michlewska S; Kołacz K; Sarkar T; Korszun J; Ionov M; Robaszkiewicz A
Biomed Pharmacother; 2023 Dec; 168():115798. PubMed ID: 37913733
[TBL] [Abstract] [Full Text] [Related]
9. Tex10 interacts with STAT3 to regulate hepatocellular carcinoma growth and metastasis.
Xiang X; Kuang W; Yu C; Li Y; Su Q; Tian Y; Li J
Mol Carcinog; 2023 Dec; 62(12):1974-1989. PubMed ID: 37792308
[TBL] [Abstract] [Full Text] [Related]
10. Oncogenic KRAS mutation confers chemoresistance by upregulating SIRT1 in non-small cell lung cancer.
Shin DH; Jo JY; Choi M; Kim KH; Bae YK; Kim SS
Exp Mol Med; 2023 Oct; 55(10):2220-2237. PubMed ID: 37779142
[TBL] [Abstract] [Full Text] [Related]
11. Network module analysis and molecular docking-based study on the mechanism of astragali radix against non-small cell lung cancer.
Xiao W; Xu Y; Baak JP; Dai J; Jing L; Zhu H; Gan Y; Zheng S
BMC Complement Med Ther; 2023 Sep; 23(1):345. PubMed ID: 37770919
[TBL] [Abstract] [Full Text] [Related]
12. Transcriptional Heterogeneity Overcomes Super-Enhancer Disrupting Drug Combinations in Multiple Myeloma.
Welsh SJ; Barwick BG; Meermeier EW; Riggs DL; Shi CX; Zhu YX; Sharik ME; Du MT; Abrego Rocha LD; Garbitt VM; Stein CK; Petit JL; Meurice N; Tafoya Alvarado Y; Fonseca R; Todd KT; Brown S; Hammond ZJ; Cuc NH; Wittenberg C; Herzog C; Roschke AV; Demchenko YN; Chen WD; Li P; Liao W; Leonard WJ; Lonial S; Bahlis NJ; Neri P; Boise LH; Chesi M; Bergsagel PL
Blood Cancer Discov; 2024 Jan; 5(1):34-55. PubMed ID: 37767768
[TBL] [Abstract] [Full Text] [Related]
13. Propionate reinforces epithelial identity and reduces aggressiveness of lung carcinoma.
Ramesh V; Gollavilli PN; Pinna L; Siddiqui MA; Turtos AM; Napoli F; Antonelli Y; Leal-Egaña A; Havelund JF; Jakobsen ST; Boiteux EL; Volante M; Faergeman NJ; Jensen ON; Siersbaek R; Somyajit K; Ceppi P
EMBO Mol Med; 2023 Dec; 15(12):e17836. PubMed ID: 37766669
[TBL] [Abstract] [Full Text] [Related]
14. KLF12 transcriptionally regulates PD-L1 expression in non-small cell lung cancer.
Pan X; Zhang W; Wang L; Guo H; Zheng M; Wu H; Weng Q; He Q; Ding L; Yang B
Mol Oncol; 2023 Dec; 17(12):2659-2674. PubMed ID: 37606530
[TBL] [Abstract] [Full Text] [Related]
15. Phase I Study of Entinostat, Atezolizumab, Carboplatin, and Etoposide in Previously Untreated Extensive-Stage Small Cell lung cancer, ETCTN 10399.
Gentzler RD; Villaruz LC; Rhee JC; Horton B; Mock J; Hanley M; Kim K; Rudek MA; Phelps MA; Carducci MA; Piekarz R; Park KS; Bullock TN; Rudin CM
Oncologist; 2023 Nov; 28(11):1007-e1107. PubMed ID: 37555284
[TBL] [Abstract] [Full Text] [Related]
16. SETD1A-mediated H3K4me3 methylation upregulates lncRNA HOXC-AS3 and the binding of HOXC-AS3 to ep300 and increases ep300 stability to suppress the ferroptosis of NSCLC cells.
Shi Z; Zhang H; Shen Y; Zhang S; Zhang X; Xu Y; Sun D
Thorac Cancer; 2023 Sep; 14(25):2579-2590. PubMed ID: 37548102
[TBL] [Abstract] [Full Text] [Related]
17. Prolonged Survival of NUT Midline Carcinoma and Current Approaches to Treatment.
Kaplan HG; Subramaniam S; Vallières E; Barnett T
Oncologist; 2023 Sep; 28(9):765-770. PubMed ID: 37311046
[TBL] [Abstract] [Full Text] [Related]
18. LPCAT3 Is Transcriptionally Regulated by YAP/ZEB/ep300 and Collaborates with ACSL4 and YAP to Determine Ferroptosis Sensitivity.
Cui J; Wang Y; Tian X; Miao Y; Ma L; Zhang C; Xu X; Wang J; Fang W; Zhang X
Antioxid Redox Signal; 2023 Sep; 39(7-9):491-511. PubMed ID: 37166352
[No Abstract] [Full Text] [Related]
19. Network pharmacology and molecular docking combined with widely targeted metabolomics to elucidate the potential compounds and targets of Euphorbia helioscopia seeds for the treatment of pulmonary fibrosis.
Liu Y; Sun W; Shen N; Hao W; Xin H; Che F; Cui Y
Comput Biol Med; 2023 Jun; 160():107007. PubMed ID: 37150086
[TBL] [Abstract] [Full Text] [Related]
20. YY1 complex in M2 macrophage promotes prostate cancer progression by upregulating IL-6.
Chen S; Lu K; Hou Y; You Z; Shu C; Wei X; Wu T; Shi N; Zhang G; Wu J; Chen S; Zhang L; Li W; Zhang D; Ju S; Chen M; Xu B
J Immunother Cancer; 2023 Apr; 11(4):. PubMed ID: 37094986
[TBL] [Abstract] [Full Text] [Related]
[Next]